International Journal of Molecular SciencesNeurosciencePeer-reviewed journal article
Ketamine Produces a Long-Lasting Enhancement of CA1 Neuron Excitability
- Citations
- 13
- FWCI
- 1.60
- Field percentile
- top 19%
Abstract
BackgroundKetamine is a clinical anaesthetic and a fast-acting, long-lasting antidepressant. Ketamine is known for its antagonistic actions on N-methyl-D-aspartate (NMDA) receptors, but mechanisms leading to antidepression are not clear. The present study examined synaptic, neuronal and circuit-level loci, the duration of ketamines actions, and the involvement of NMDA receptors in these actions. MethodsExtracellular evoked field potentials were recorded from the CA1 region of mouse hippocampal slices. Ketamine was tested at antidepressant (10 M) and anaesthetic (350 M) concentrations. Effects of NMDA receptor antagonists, DL-2-Amino-5-phosphonovaleric acid (APV) and MK-801, {gamma}-aminobutyric acid (GABA) receptor antagonist bicuculline, and a potassium channel blocker tetraethylammonium (TEA) were also studied. ResultsKetamine decreased population spike (PS) amplitudes during application, but a long-lasting increase in PS amplitudes was seen during washout of ketamine. While the acute effects of ketamine were reversed by bicuculline, the washout increase was not altered. This long-term increase was statistically significant (p2 hours, and involved postsynaptic mechanisms. A similar, long-lasting effect was produced by MK-801 but was only partially evident with APV, demonstrating the importance of channel block downstream of NMDA receptors. Furthermore, TEA produced a lasting excitability increase, indicating possible involvement of potassium channel block in ketamines long-term effects. ConclusionsThis is this first report of a long-lasting increase in excitability following ketamine exposure. These results support a growing literature that increased GABA inhibition contributes to ketamine anaesthesia, while increased excitatory transmission contributes to its antidepressant effects. Published AbstractsSociety for Neuroscience Annual Meeting 2019 Association of University Anesthesiologists Annual Meeting 2020 International Anesthesia Research Society Annual Meeting 2020 The Science of Consciousness Conference 2020 International Society for Anaesthetic Pharmacology Annual Meeting 2020 Western Anesthesia Residents Conference 2021 Association of University Anesthesiologists Annual Meeting 2021 International Anesthesia Research Society Annual Meeting 2021
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ketamines rapid antidepressant effects are mediated by Ca2+ - permeable AMPA receptors in the hippocampus
Anastasiya Zaytseva, Evelina Bouckova, … Seonil Kim·eLifePeer-reviewed·Jun 26, 2023
- N1 cassette-lacking NMDA receptors mediate the antidepressant activity of ketamine
Alina Tao He, Wenbo Zhang, … Michael W. Salter·bioRxiv·Apr 12, 2025
- Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine
Thu Ha Pham, Céline Defaix, … Alain Michel Gardier·Pharmacology Biochemistry and BehaviorPeer-reviewed·Mar 19, 2020
- Ketamine selectively enhances AMPA neurotransmission onto a subgroup of identified serotoninergic neurons of the rat dorsal raphe
Cyrine Hmaied, Stanislav Koulchitsky, … Vincent Seutin·bioRxiv·Aug 19, 2020
- Ketamine potentiates a central glutamatergic presynapse
Abdelmoneim Eshra, Noa Lipstein, Stefan Hallermann·bioRxiv·Dec 17, 2023
- Opioid receptor expressing neurons of the central amygdala gate behavioral effects of ketamine in mice
Matthew B. Pomrenze, Sam Vaillancourt, … Boris Dov Heifets·bioRxiv·Mar 3, 2024